Vaccinex, Inc. Faces Listing Rule Concerns
Ticker: VCNX · Form: 8-K · Filed: Mar 7, 2025 · CIK: 1205922
| Field | Detail |
|---|---|
| Company | Vaccinex, Inc. (VCNX) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, pharmaceuticals
TL;DR
Vaccinex might get delisted - big trouble for shareholders.
AI Summary
On March 7, 2025, Vaccinex, Inc. filed an 8-K report indicating a potential delisting or failure to meet continued listing standards. The company, incorporated in Delaware with its principal executive offices in Rochester, NY, is classified under Pharmaceutical Preparations.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the company's stock being delisted, impacting investors.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a severe indicator of financial instability or significant operational issues.
Key Numbers
- 16-1603202 — IRS Employer Identification No. (Identifies the company for tax purposes.)
- 2834 — Standard Industrial Classification (Indicates the company operates in Pharmaceutical Preparations.)
Key Players & Entities
- Vaccinex, Inc. (company) — Registrant
- March 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Rochester, New York (location) — Address of principal executive offices
- 001-38624 (identifier) — Commission File Number
FAQ
What specific listing rule or standard has Vaccinex, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Vaccinex, Inc. has failed to satisfy, only that it is a notice of delisting or failure to meet a continued listing rule or standard.
What is the potential consequence of failing to meet continued listing standards?
The potential consequence is delisting from the stock exchange, which means the company's securities would no longer be traded on that exchange.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 7, 2025.
Where are Vaccinex, Inc.'s principal executive offices located?
Vaccinex, Inc.'s principal executive offices are located at 1895 Mount Hope Avenue, Rochester, New York 14620.
What is Vaccinex, Inc.'s Standard Industrial Classification code?
Vaccinex, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 7, 2025 regarding VACCINEX, INC. (VCNX).